In this episode, host Brandon Miller is joined by Steven Lynn, Executive Vice President of Pharmaceuticals at Regulatory Compliance Associates (RCA), and Susan Schniepp, RCA’s Distinguished Fellow, to discuss the critical topics of quality metrics, quality culture, and data integrity in the pharmaceutical industry. These issues are of paramount concern to both industry professionals and regulatory authorities, especially in light of recent developments and permanent changes brought about by the pandemic.
Brandon, Steven, and Susan delve into why data integrity and quality culture are more crucial now than ever before. They explore the permanent shifts in regulatory expectations and industry practices that have emerged due to the pandemic, and how these changes can be leveraged to improve overall quality and compliance. The discussion highlights the interconnection between data integrity and quality culture, emphasizing that maintaining accurate and reliable data is essential for fostering a robust quality culture within any organization.
Listeners will gain insights into the reasons behind the heightened focus on data integrity and quality culture by regulatory bodies and learn about the best practices for embedding these principles into their organizational framework. Steven and Susan share their expertise on how to create and sustain a culture that prioritizes data integrity, ensuring that all employees understand their role in maintaining the highest standards of quality.
This episode is a must-listen for pharmaceutical professionals, quality assurance specialists, and regulatory compliance experts who want to stay ahead of the curve in understanding and implementing quality metrics, quality culture, and data integrity. By tuning in, you will learn how to navigate the evolving regulatory landscape and enhance your organization’s commitment to quality.
Join us for a deep dive into these essential topics and discover strategies to strengthen your quality culture and data integrity practices.